Effectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in Children: a Multicentre European Randomized Controlled Trial
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 27 Mar 2018
At a glance
- Drugs Immune globulin (Primary) ; Albumin human
- Indications Septic shock; Staphylococcal infections; Streptococcal infections
- Focus Therapeutic Use
- Acronyms IGHN2
- 26 Feb 2018 Planned End Date changed from 1 Jan 2021 to 1 Apr 2022.
- 26 Feb 2018 Planned primary completion date changed from 1 Jan 2021 to 1 Apr 2022.
- 26 Feb 2018 Planned initiation date changed from 1 Jan 2017 to 1 Apr 2018.